A phantom study on fetal dose reducing factors in pregnant patients with breast cancer during radiotherapy treatment

Purpose: This study aims to investigate the factors that reduce fetal dose in pregnant patients with breast cancer throughout their radiation treatment. Two main factors in a standard radiation oncology center are considered as the treatment planning systems (TPSs) and simple shielding for intensity...

Full description

Bibliographic Details
Main Authors: Akın Ogretici, Aydın Çakır, Uğur Akbaş, Canan Köksal, Ümmühan Kalafat, Makbule Tambaş, Hatice Bilge
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2017-01-01
Series:Journal of Medical Physics
Subjects:
Online Access:http://www.jmp.org.in/article.asp?issn=0971-6203;year=2017;volume=42;issue=3;spage=128;epage=132;aulast=Ogretici
id doaj-77368880338d41e793977f76d2dab0e1
record_format Article
spelling doaj-77368880338d41e793977f76d2dab0e12020-11-25T00:05:37ZengWolters Kluwer Medknow PublicationsJournal of Medical Physics0971-62031998-39132017-01-0142312813210.4103/jmp.JMP_133_16A phantom study on fetal dose reducing factors in pregnant patients with breast cancer during radiotherapy treatmentAkın OgreticiAydın ÇakırUğur AkbaşCanan KöksalÜmmühan KalafatMakbule TambaşHatice BilgePurpose: This study aims to investigate the factors that reduce fetal dose in pregnant patients with breast cancer throughout their radiation treatment. Two main factors in a standard radiation oncology center are considered as the treatment planning systems (TPSs) and simple shielding for intensity modulated radiation therapy technique. Materials and Methods: TPS factor was evaluated with two different planning algorithms: Anisotropic analytical algorithm and Acuros XB (external beam). To evaluate the shielding factor, a standard radiological purpose lead apron was chosen. For both studies, thermoluminescence dosimeters were used to measure the point dose, and an Alderson RANDO-phantom was used to simulate a female pregnant patient in this study. Thirteen measurement points were chosen in the 32nd slice of the phantom to cover all possible locations of a fetus up to 8th week of gestation. Results: The results show that both of the TPS algorithms are incapable of calculating the fetal doses, therefore, unable to reduce them at the planning stage. Shielding with a standard lead apron, however, showed a slight radiation protection (about 4.7%) to the fetus decreasing the mean fetal dose from 84.8 mGy to 80.8 mGy, which cannot be disregarded in case of fetal irradiation. Conclusions: Using a lead apron for shielding the abdominal region of a pregnant patient during breast irradiation showed a minor advantage; however, its possible side effects (i.e., increased scattered radiation and skin dose) should also be investigated further to solidify its benefits.http://www.jmp.org.in/article.asp?issn=0971-6203;year=2017;volume=42;issue=3;spage=128;epage=132;aulast=OgreticiFetal doseintensity modulated radiation therapypregnancyshieldingtreatment planning system
collection DOAJ
language English
format Article
sources DOAJ
author Akın Ogretici
Aydın Çakır
Uğur Akbaş
Canan Köksal
Ümmühan Kalafat
Makbule Tambaş
Hatice Bilge
spellingShingle Akın Ogretici
Aydın Çakır
Uğur Akbaş
Canan Köksal
Ümmühan Kalafat
Makbule Tambaş
Hatice Bilge
A phantom study on fetal dose reducing factors in pregnant patients with breast cancer during radiotherapy treatment
Journal of Medical Physics
Fetal dose
intensity modulated radiation therapy
pregnancy
shielding
treatment planning system
author_facet Akın Ogretici
Aydın Çakır
Uğur Akbaş
Canan Köksal
Ümmühan Kalafat
Makbule Tambaş
Hatice Bilge
author_sort Akın Ogretici
title A phantom study on fetal dose reducing factors in pregnant patients with breast cancer during radiotherapy treatment
title_short A phantom study on fetal dose reducing factors in pregnant patients with breast cancer during radiotherapy treatment
title_full A phantom study on fetal dose reducing factors in pregnant patients with breast cancer during radiotherapy treatment
title_fullStr A phantom study on fetal dose reducing factors in pregnant patients with breast cancer during radiotherapy treatment
title_full_unstemmed A phantom study on fetal dose reducing factors in pregnant patients with breast cancer during radiotherapy treatment
title_sort phantom study on fetal dose reducing factors in pregnant patients with breast cancer during radiotherapy treatment
publisher Wolters Kluwer Medknow Publications
series Journal of Medical Physics
issn 0971-6203
1998-3913
publishDate 2017-01-01
description Purpose: This study aims to investigate the factors that reduce fetal dose in pregnant patients with breast cancer throughout their radiation treatment. Two main factors in a standard radiation oncology center are considered as the treatment planning systems (TPSs) and simple shielding for intensity modulated radiation therapy technique. Materials and Methods: TPS factor was evaluated with two different planning algorithms: Anisotropic analytical algorithm and Acuros XB (external beam). To evaluate the shielding factor, a standard radiological purpose lead apron was chosen. For both studies, thermoluminescence dosimeters were used to measure the point dose, and an Alderson RANDO-phantom was used to simulate a female pregnant patient in this study. Thirteen measurement points were chosen in the 32nd slice of the phantom to cover all possible locations of a fetus up to 8th week of gestation. Results: The results show that both of the TPS algorithms are incapable of calculating the fetal doses, therefore, unable to reduce them at the planning stage. Shielding with a standard lead apron, however, showed a slight radiation protection (about 4.7%) to the fetus decreasing the mean fetal dose from 84.8 mGy to 80.8 mGy, which cannot be disregarded in case of fetal irradiation. Conclusions: Using a lead apron for shielding the abdominal region of a pregnant patient during breast irradiation showed a minor advantage; however, its possible side effects (i.e., increased scattered radiation and skin dose) should also be investigated further to solidify its benefits.
topic Fetal dose
intensity modulated radiation therapy
pregnancy
shielding
treatment planning system
url http://www.jmp.org.in/article.asp?issn=0971-6203;year=2017;volume=42;issue=3;spage=128;epage=132;aulast=Ogretici
work_keys_str_mv AT akınogretici aphantomstudyonfetaldosereducingfactorsinpregnantpatientswithbreastcancerduringradiotherapytreatment
AT aydıncakır aphantomstudyonfetaldosereducingfactorsinpregnantpatientswithbreastcancerduringradiotherapytreatment
AT ugurakbas aphantomstudyonfetaldosereducingfactorsinpregnantpatientswithbreastcancerduringradiotherapytreatment
AT canankoksal aphantomstudyonfetaldosereducingfactorsinpregnantpatientswithbreastcancerduringradiotherapytreatment
AT ummuhankalafat aphantomstudyonfetaldosereducingfactorsinpregnantpatientswithbreastcancerduringradiotherapytreatment
AT makbuletambas aphantomstudyonfetaldosereducingfactorsinpregnantpatientswithbreastcancerduringradiotherapytreatment
AT haticebilge aphantomstudyonfetaldosereducingfactorsinpregnantpatientswithbreastcancerduringradiotherapytreatment
AT akınogretici phantomstudyonfetaldosereducingfactorsinpregnantpatientswithbreastcancerduringradiotherapytreatment
AT aydıncakır phantomstudyonfetaldosereducingfactorsinpregnantpatientswithbreastcancerduringradiotherapytreatment
AT ugurakbas phantomstudyonfetaldosereducingfactorsinpregnantpatientswithbreastcancerduringradiotherapytreatment
AT canankoksal phantomstudyonfetaldosereducingfactorsinpregnantpatientswithbreastcancerduringradiotherapytreatment
AT ummuhankalafat phantomstudyonfetaldosereducingfactorsinpregnantpatientswithbreastcancerduringradiotherapytreatment
AT makbuletambas phantomstudyonfetaldosereducingfactorsinpregnantpatientswithbreastcancerduringradiotherapytreatment
AT haticebilge phantomstudyonfetaldosereducingfactorsinpregnantpatientswithbreastcancerduringradiotherapytreatment
_version_ 1725424201943220224